Increased expression of glucose transporter 1 (GLUT1) in RCC is associated with reduced CD8+ T cell infiltration, which implies that GLUT1 plays a role in the immune evasion of renal cancer cells [57]. Here, SLC2A1 is linked to renal carcinoma.